Literature DB >> 18302520

Maternal, infant, and delivery factors associated with neonatal thyroid hormone status.

Julie Herbstman1, Benjamin J Apelberg, Frank R Witter, Susan Panny, Lynn R Goldman.   

Abstract

BACKGROUND: Thyroid function is dynamic during the perinatal period with many factors potentially influencing maternal, fetal and neonatal TSH and thyroid hormone levels. We sought to identify the impact of numerous maternal, fetal and delivery attributes on thyroid parameters in newborns.
METHODS: This was a cross sectional study of 300 newborns. Detailed information was obtained from medical records and multiple characteristics from the record were tested as predictors of cord blood serum total T4, free T4 and TSH and infant T4 levels from the Maryland newborn screening program. MAIN OUTCOME: Outcomes are levels of thyroid stimulating hormone (TSH), thyroxine (T(4)), and free T(4) in newborn cord serum and total T(4) in postnatal heelstick bloodspot samples.
RESULTS: Multivariate models identified a number of variables that are independently associated with thyroid hormone levels: higher birth order (lower cord TSH); older maternal age (lower cord total T(4)); pregnancy-induced hypertension and/or preeclampsia (lower cord total T(4) and free T(4)); gestational diabetes (higher cord free T(4)); sexually transmitted disease during pregnancy (lower cord TSH); alcohol use during pregnancy (lower cord TSH); thyroid condition/medications (higher bloodspot total T(4), both neonatal and subsequent); Asian ancestry (higher cord TSH); male sex (higher TSH and lower neonatal bloodspot total T(4)); and C-section (lower cord TSH). Gestational age was independently associated with lower cord TSH, higher cord total T(4), and higher neonatal and subsequent bloodspot total T(4).
CONCLUSIONS: Fetal and newborn thyroid hormone levels during the perinatal period are dynamic and influenced by several biological and delivery related factors. Efforts to identify fetal thyroid disruptors in late gestation must carefully consider these factors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18302520     DOI: 10.1089/thy.2007.0180

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  32 in total

1.  Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone.

Authors:  Kelli K Ryckman; Cassandra N Spracklen; John M Dagle; Jeffrey C Murray
Journal:  J Pediatr Endocrinol Metab       Date:  2014-09       Impact factor: 1.634

2.  Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds.

Authors:  Rafael Guerrero-Preston; Lynn R Goldman; Priscilla Brebi-Mieville; Carmen Ili-Gangas; Cynthia Lebron; Frank R Witter; Ben J Apelberg; Marina Hernández-Roystacher; Andrew Jaffe; Rolf U Halden; David Sidransky
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

3.  Associations between brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates.

Authors:  Merete Eggesbø; Cathrine Thomsen; Jens V Jørgensen; Georg Becher; Jon Øyvind Odland; Matthew P Longnecker
Journal:  Environ Res       Date:  2011-05-20       Impact factor: 6.498

4.  Gestational urinary bisphenol A and maternal and newborn thyroid hormone concentrations: the HOME Study.

Authors:  Megan E Romano; Glenys M Webster; Ann M Vuong; R Thomas Zoeller; Aimin Chen; Andrew N Hoofnagle; Antonia M Calafat; Margaret R Karagas; Kimberly Yolton; Bruce P Lanphear; Joseph M Braun
Journal:  Environ Res       Date:  2015-03-17       Impact factor: 6.498

5.  The role of placental iodine storage in the neonatal thyroid stimulating hormone surge: iodine as a driving force to adapt the terrestrial life.

Authors:  M Karaoglan; E İşbilen
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256

6.  Thyroxine administration prevents matrilineal intergenerational consequences of in utero ethanol exposure in rats.

Authors:  Elif Tunc-Ozcan; Kathryn M Harper; Evan N Graf; Eva E Redei
Journal:  Horm Behav       Date:  2016-04-16       Impact factor: 3.587

7.  Thyroid-stimulating hormone levels in newborns and early life exposure to endocrine-disrupting chemicals: analysis of three European mother-child cohorts.

Authors:  Marijke de Cock; Michiel R de Boer; Eva Govarts; Nina Iszatt; Lubica Palkovicova; Marja H Lamoree; Greet Schoeters; Merete Eggesbø; Tomas Trnovec; Juliette Legler; Margot van de Bor
Journal:  Pediatr Res       Date:  2017-06-07       Impact factor: 3.756

Review 8.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement.

Authors:  Evanthia Diamanti-Kandarakis; Jean-Pierre Bourguignon; Linda C Giudice; Russ Hauser; Gail S Prins; Ana M Soto; R Thomas Zoeller; Andrea C Gore
Journal:  Endocr Rev       Date:  2009-06       Impact factor: 19.871

9.  Maternal urinary phthalate metabolites during pregnancy and thyroid hormone concentrations in maternal and cord sera: The HOME Study.

Authors:  Megan E Romano; Melissa N Eliot; R Thomas Zoeller; Andrew N Hoofnagle; Antonia M Calafat; Margaret R Karagas; Kimberly Yolton; Aimin Chen; Bruce P Lanphear; Joseph M Braun
Journal:  Int J Hyg Environ Health       Date:  2018-03-23       Impact factor: 5.840

10.  Associations of Exposure to Perfluoroalkyl Substances With Thyroid Hormone Concentrations and Birth Size.

Authors:  Christina Xiao; Philippe Grandjean; Damaskini Valvi; Flemming Nielsen; Tina Kold Jensen; Pal Weihe; Youssef Oulhote
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.